You are currently viewing American Drug Administration Clears Exoskeleton Robot For Stroke Patients

American Drug Administration Clears Exoskeleton Robot For Stroke Patients

The United States Food and Drug Administration (FDA) has cleared Atalante exoskeleton robot to be used for stroke patients during rehabilitation.


Made by Wandercraft, the robot can help during intensive physiotherapy sessions like gait training and more. According to Engagdet, which relayed the news, the robot features self-balancing tech.


In addition, it can be adjusted to help during different stages of gait recovery. For now, the robot is only approved for clinical use and in the presence of a therapist.


Wandercraft Atalante exoskeleton
Wandercraft Atalante exoskeleton. Image Source: Wandercraft.


The makers are eyeing a first quarter of 2023 shipping date but has not revealed which customers have placed orders already.


Also read:
Tech Layoffs: Google To Fire 12,000 Employees
Theranos Elizabeth Holmes Attempted To Flee After Fraud Conviction
How Google Plans To Fend Off ChatGPT Threat.


Progress in the exoskeleton industry has not been as explosive as many of us thought, which is surprising considering how useful they could be. In the US, robots such as these that have been cleared by the FDA, are still not mainstream yet.


Need to know: Exoskeleton robots or devices are wearable devices that are worn over the body, typically on the legs or arms, to provide additional support and strength to the wearer. They can be powered by motors or hydraulics, and can be controlled by the wearer or by a computer. Exoskeletons can be used for a variety of applications, such as assisting people with mobility impairments, enhancing the physical capabilities of healthy individuals, and performing industrial tasks that require heavy lifting or repetitive motions.


Ekso Bionics, a competitor, received approval from the FDA to begin selling its EksoNR robot in June 2022. More recently, Elon Musk spoke about the possibility of Neuralink technology helping people that lose mobility in a part of their body to recover it. Although, he did not say when this will become available, we only last heard that the company got clearance to begin human trials in 2023.


For your daily dose of tech, lifestyle, and trending content, make sure to follow Plat4om on Twitter @Plat4omLive, on Instagram @Plat4om, on LinkedIn at Plat4om, and on Facebook at Plat4om. You can also email us at and join our channel on Telegram at Plat4om. Finally, don’t forget to subscribe to OUR YOUTUBE CHANNEL.

Onwuasoanya Obinna

A reader of books and stringer of words. Passionate about Science and Tech. When not writing or reading he is surfing the web and Tweeting.